Limiting fibrosis after myocardial infarction.
Jugdutt
Bodh I
BI
Division of Cardiology, Department of Medicine and Cardiovascular Research Group, Faculty of Medicine, University of Alberta, Edmonton, Canada.
D000818:Animals; D055395:Bone Morphogenetic Protein 1 / Q000378:metabolism; D024042:Collagen Type I / Q000096:biosynthesis; D005355:Fibrosis / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology*; D015398:Signal Transduction; D051153:Wnt Proteins / Q000378:metabolism*; D000094742:Secreted Frizzled-Related Proteins
D055395:Bone Morphogenetic Protein 1; D024042:Collagen Type I; D020782:Matrix Metalloproteinases; D008565:Membrane Proteins; D051153:Wnt Proteins; C491628:Sfrp2 protein, mouse; D000094742:Secreted Frizzled-Related Proteins